To explore the value of biological agents in the treatment of rheumatic immune diseases
探究生物制剂在风湿免疫病治疗中的价值

摘要

目的 探究生物制剂在风湿免疫病治疗中的价值。方法 研究时间选择在2019年1月-2021年12月，将此期间我院收治的65例风湿免疫病患者，随机将患者分为对照组和实验组，对照组32例患者采用常规药物治疗，实验组33例患者采用生物制剂进行治疗，分析应用效果。结果 实验组患者临床症状改善时间以及各临床指标恢复情况均优于对照组，且不良反应低于对照组，对比生活质量，实验组优于对照组，P＜0.05。结论 生物制剂能够更加高效的帮助患者缓解临床症状，减轻患者的痛苦，同时，在治疗期间患者不会出现明显的不良反应，具有较高的治疗安全性，有效提高患者的生活质量。

Abstract

Objective To explore the value of biological agents in the treatment of rheumatic immune diseases.
Methods: the study time was from January 2019 to December 2021. 126 patients with rheumatic immune disease treated in our hospital during this period were randomly divided into control group and experimental group, with 63 patients in each group. The control group was treated with conventional drugs and the experimental group was treated with biological agents, and the application effect was analyzed.
Results: the improvement time of clinical symptoms and the recovery of clinical indexes in the experimental group were better than those in the control group, and the adverse reactions were lower than those in the control group. Compared with the quality of life, the experimental group was better than the control group (P < 0.05).
Conclusion  : biological agents can more effectively help patients alleviate clinical symptoms and alleviate patients' pain. At the same time, patients will not have obvious adverse reactions during treatment. They have high treatment safety and effectively improve patients' quality of life.